investors

SEC Filings

Filing date Form Description View
8-K

Report of unscheduled material events or corporate event

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
PRER14A

Proxy soliciting materials. Revised preliminary material

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
4

Statement of changes in beneficial ownership of securities

View HTML
Copyright 2018 by Immunocellular Therapeutics, Ltd.
All Rights Reserved